SCHEMBL4774025

SCHEMBL4774025

CCC(Cc1cc(C(C)C)nn1Cc1ccc(Cl)cc1Cl)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 12/20 0.53
NPC1 O15118 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
PMP22 Q01453 1/20 0.44
HIF1A Q16665 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
JAK2 O60674 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
HTT P42858 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SLC16A3 O15427 2/20 0.42
SLC16A1 P53985 2/20 0.42
MCTS1 Q9ULC4 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3206403 0.81 PPARG (0.74) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL3207494 0.80 PPARG (0.53) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL4774031 0.76 PPARG (0.49) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL3208410 0.76 PPARG (0.61) PPARG
SCHEMBL5108762 0.75 PPARG (0.57) PPARGNPC1
SCHEMBL3204985 0.73 PPARG (0.64) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL3210282 0.73 NPC1 (0.51) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL3204975 0.73 PPARG (0.64) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL3216020 0.71 PPARG (0.54) PPARGNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL5107833 0.70 PPARG (0.56) PPARGSLC16A3SLC16A1MCTS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed